Арилжаа DBV Technologies SA - DBV CFD

Арилжааны нөхцөл

• Төрөл: CFD
• Спред: 0.03
• Лонг позицын шөнийн санхүүжилтийн тохируулга: -0.01661%
• Шорт позицын нэг шөнийн санхүүжилтийн тохируулга: -0.00561%
• Шөнийн санхүүжилтийг тохируулах хугацаа: 22:00 (UTC)
• Валют: EUR
• Арилжаалсан доод хэмжээ: 10
• Маржин: 5.00%
• Хөрөнгийн бирж: France
• Арилжааны шимтгэл: 0%
• Баталгаат стопын шимтгэл: 1%

Гол үзүүлэлтүүд

• Өмнөх Хаах: 3.86
• Нээх: 3.83
• 1 жилийн өөрчлөлт: 345.35%
• Өдрийн диапазон: 3.83 - 3.95

DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.